Conducting clinical trials in trauma care is challenging. As new treatments become available, we are faced with the dilemma of how to confirm their effectiveness, and strengthen the evidence base. Randomized controlled trials are the gold standard, but target groups in trauma care are often small and specialized, making the classical approach to trial design difficult. Bayesian designs represent an innovative means of increasing trial efficiency, and conducting trials with more realistic sample sizes. This article examines the design of such trials, using the UK-REBOA Trial as an example
Background The Bayesian approach is being used increasingly in medical research. In particular, it h...
In the last decade, the number of clinical trials using Bayesian methods has grown dramatically. Now...
BACKGROUND Phase III trials often require large sample sizes, leading to high costs and delays in...
Conducting clinical trials in trauma care is challenging. As new treatments become available, we are...
Conducting clinical trials in trauma care is challenging. As new treatments become available, we are...
The UK-REBOA Trial is funded by the National Institute for Health Research (NIHR) Health Technology ...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
Background: Phase III trials often require large sample sizes, leading to high costs and delays in ...
Recent Bayesian reanalyses of prominent trials in critical illness have generated controversy by con...
Background: Given the success of recent platform trials for COVID-19, Bayesian statistical methods h...
BACKGROUND Phase III trials often require large sample sizes, leading to high costs and delays in...
Background The Bayesian approach is being used increasingly in medical research. In particular, it h...
In the last decade, the number of clinical trials using Bayesian methods has grown dramatically. Now...
BACKGROUND Phase III trials often require large sample sizes, leading to high costs and delays in...
Conducting clinical trials in trauma care is challenging. As new treatments become available, we are...
Conducting clinical trials in trauma care is challenging. As new treatments become available, we are...
The UK-REBOA Trial is funded by the National Institute for Health Research (NIHR) Health Technology ...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
International audienceBACKGROUND:The common frequentist approach is limited in providing investigato...
Background: Phase III trials often require large sample sizes, leading to high costs and delays in ...
Recent Bayesian reanalyses of prominent trials in critical illness have generated controversy by con...
Background: Given the success of recent platform trials for COVID-19, Bayesian statistical methods h...
BACKGROUND Phase III trials often require large sample sizes, leading to high costs and delays in...
Background The Bayesian approach is being used increasingly in medical research. In particular, it h...
In the last decade, the number of clinical trials using Bayesian methods has grown dramatically. Now...
BACKGROUND Phase III trials often require large sample sizes, leading to high costs and delays in...